Floatz logo

Fludarabine

Post-Transplant Lymphoproliferative Disease

City of Hope Medical CenterSmall moleculePhase 2Active
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
60/ 100
Competitive Position
81/ 100

Competitive context

16 Active assets in the Post-Transplant Lymphoproliferative Disease cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
Washington University School of Medicine
Phase 2BBB
Rituximab
Jennifer Amengual
Phase 2BB
Cyclosporin A
National Cancer Institute (NCI)
Phase 2BB
Methotrexate
National Cancer Institute (NCI)
Phase 2BB
Lenalidomide
Northwestern University
Phase 2B

View all 47 →

Same molecule, other indications

Fludarabine is also rated in:

adult T-cell leukemia/lymphomaActive
BBB
Indicative · Phase 2
76 / 100
View asset →
acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)Dormant
BBB
Indicative · Phase 2
76 / 100
View asset →
Fanconi anemiaActive
BBB
Indicative · Phase 2/3
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →